Desensibilización y taquifilaxia

Tachyphylaxis is a rapid decrease in drug response after repeated or continuous administration of the same dose. It occurs because persistent drug exposure desensitizes receptors through cellular mechanisms including receptor phosphorylation, beta-arrestin binding, receptor internalization, and depletion of signaling molecules. These adaptive changes reduce the body's responsiveness over time.

When a beta-adrenoceptor is continuously activated, a GPCR kinase phosphorylates the activated receptor. The phosphorylated receptor tightly binds beta-arrestin, which blocks additional G protein binding and causes rapid receptor inactivation. This mechanism is central to how transducer mechanism G protein-coupled receptors lose responsiveness during prolonged drug exposure.

Beta-arrestin facilitates clathrin assembly on the plasma membrane, internalizing the beta-arrestin-receptor complex into a vesicle and sequestering it in an endosome. If the endosome fuses with a lysosome, lysosomal enzymes degrade the internalized receptor, permanently removing it from the cell surface and reducing drug responsiveness.

Excessive amphetamine use depletes dopamine reserves at the presynaptic nerve terminal by releasing stored amines. With repeated dosing, the body's supply of dopamine becomes exhausted, halting neurotransmission and causing the drug to become progressively less effective despite continued administration at the same dose.

Tachyphylaxis may necessitate increasing drug doses to maintain effectiveness or switching to alternative treatments. Understanding this adaptive process is important for optimizing drug therapy and developing strategies to mitigate tachyphylaxis, ensuring patients maintain desired therapeutic effects over time despite repeated dosing.

Yes, internalized receptors can be recycled back to the plasma membrane when drug levels drop, allowing potential recovery of receptor responsiveness. However, if endosomes fuse with lysosomes, the receptors are permanently degraded and must be newly synthesized to restore full drug sensitivity.

Tachyphylaxis is a rapid decrease in response occurring within hours or days of repeated dosing, caused by receptor desensitization or depletion of signaling molecules. It represents an acute adaptive change distinct from tolerance, which develops more slowly through multiple physiological compensatory mechanisms over longer periods.